Latest News of VRTX
Vertex Pharmaceuticals (VRTX) Q3 2024 Earnings Call Transcript
By Yahoo! Finance |
3 days ago
Vertex Pharmaceuticals recently held a call discussing their Q3 results and future plans. They highlighted strong performance in their CF and CASGEVY launches, with potential approvals in early 2025....
Vertex Pharmaceuticals Incorporated (VRTX): Why Do Hedge Funds Recommend This Biotech Stock?
By Yahoo! Finance |
2 months ago
A review of the 12 Best Biotech Stocks by hedge funds includes a spotlight on Vertex Pharmaceuticals (NASDAQ:VRTX). The biotech industry is projected to grow significantly, with Vertex being a top con...
Vertex Pharmaceutical Inc. (VRTX): Jim Cramer's Go-To Stock For Success
By Yahoo! Finance |
2 months ago
The article discusses Jim Cramer's views on Nvidia's market behavior and the broader implications for investors. Despite strong financial performance, the stock fell due to high expectations. Cramer s...
-
Vertex Pharmaceuticals Incorpor (VRTX) Stock Forecasts
By Yahoo! Finance | 3 months agoJasper Hellweg, an Associate Analyst at Argus Research, specializes in Growth Pharmaceutical, Medical Technology, and Financial Technology sectors. With a background in business administration, he con...
-
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Just Reported Second-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?
By Yahoo! Finance | 3 months agoVertex Pharmaceuticals reported revenues of US$2.6b, in line with expectations, but also reported losses of US$13.92 per share, slightly higher than expected. Analysts forecast a 4....
-
Vertex Pharmaceuticals (VRTX) Q2 2024 Earnings Call Transcript
By Yahoo! Finance | 3 months agoVertex Pharmaceuticals held its Q2 2024 earnings call, discussing financial results and future outlook. Executives highlighted strong performance, potential launches, and promising developments in var...
-
Insider Sale at Vertex Pharmaceuticals Inc (VRTX) by EVP and CMO Carmen Bozic
By Yahoo! Finance | 3 months agoCarmen Bozic, Chief Medical Officer of Vertex Pharmaceuticals Inc, sold 2,280 shares at $488.46 each, owning 25,539 shares after the sale. The company focuses on developing medicines for serious disea...
-
Insider Sale: EVP and CMO Carmen Bozic Sells Shares of Vertex Pharmaceuticals Inc (VRTX)
By Yahoo! Finance | 3 months agoCarmen Bozic, Chief Medical Officer of Vertex Pharmaceuticals Inc, recently sold 2,280 shares at $487.34 each, owning 27,819 shares after the sale. The company focuses on developing therapies for seri...
-
Insider Sale at Vertex Pharmaceuticals Inc (VRTX): EVP and CMO Carmen Bozic Sells 2,280 Shares
By Yahoo! Finance | 4 months agoCarmen Bozic, EVP and CMO of Vertex Pharmaceuticals Inc (NASDAQ:VRTX), sold 2,280 shares at $471.72 per share. With 30,099 shares remaining, Bozic has sold 40,745 shares in the past year....
-
Vertex (VRTX) Rises 16.5% YTD: Time to Bet On the Stock?
By Yahoo! Finance | 4 months agoVertex Pharmaceuticals (VRTX) has shown strong revenue growth and stock performance due to its dominance in the cystic fibrosis market and successful pipeline developments, including approvals for gen...
-
Vertex Pharmaceutical Incorporated. (VRTX): Analysts are Bullish on this Healthcare Stock's Strong Financial Performance in Q1
By Yahoo! Finance | 4 months agoThe article discusses the healthcare industry's growth trends and focuses on Vertex Pharmaceuticals (NASDAQ:VRTX), highlighting its strong financial performance and product revenues. It also mentions ...
-
Vertex Pharmaceuticals (NASDAQ:VRTX): The Best Healthcare Stock to Buy in 2024?
By Yahoo! Finance | 4 months agoVenu Krishna from Barclays recommends Vertex Pharmaceuticals (NASDAQ:VRTX) to diversify your portfolio away from big tech stocks. Vertex's strong growth catalysts and pipeline make it a smart long-ter...
-
Vertex Pharmaceuticals Incorporated (VRTX) Stock Price, News, Quote & History
By Yahoo! Finance | 4 months agoVertex Pharmaceuticals presented positive long-term data on CASGEVY™ at the 2024 EHA Congress. The results confirm consistent and durable clinical benefits for patients with severe SCD or TDT, align...
-
Vertex Pharmaceuticals Incorporated (VRTX): A Promising Feminist Stock To Buy?
By Yahoo! Finance | 4 months agoThe article discusses the increasing role of women in leadership positions and the narrowing gender pay gap. It also highlights Vertex Pharmaceuticals (NASDAQ:VRTX) as one of the best feminist stocks ...
-
Investors Heavily Search Vertex Pharmaceuticals Incorporated (VRTX): Here is What You Need to Know
By Yahoo! Finance | 4 months agoVertex Pharmaceuticals has been trending on Zacks.com due to its +12.4% return in the past month. Analysts focus on earnings estimate revisions, with the current stock rating of Zacks Rank #3 (Hold)....